UY32500A - Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable - Google Patents

Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable

Info

Publication number
UY32500A
UY32500A UY0001032500A UY32500A UY32500A UY 32500 A UY32500 A UY 32500A UY 0001032500 A UY0001032500 A UY 0001032500A UY 32500 A UY32500 A UY 32500A UY 32500 A UY32500 A UY 32500A
Authority
UY
Uruguay
Prior art keywords
pharmaceutically acceptable
acceptable acid
salts
ivabradina
addition
Prior art date
Application number
UY0001032500A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Aimee Dessinges
Bernard Serkiz
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40984744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY32500(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY32500A publication Critical patent/UY32500A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedimiento de síntesis de la ivabradina de fórmula (I) y de sus sales de adición a un ácido farmacéuticamente aceptable.
UY0001032500A 2009-03-31 2010-03-17 Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable UY32500A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901555A FR2943667B1 (fr) 2009-03-31 2009-03-31 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.

Publications (1)

Publication Number Publication Date
UY32500A true UY32500A (es) 2010-09-30

Family

ID=40984744

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032500A UY32500A (es) 2009-03-31 2010-03-17 Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable

Country Status (37)

Country Link
US (1) US8101747B2 (es)
EP (1) EP2241554B1 (es)
JP (1) JP5107382B2 (es)
KR (1) KR101166630B1 (es)
CN (2) CN102603634B (es)
AR (1) AR075977A1 (es)
AT (1) ATE523494T1 (es)
AU (1) AU2010201058B2 (es)
BR (1) BRPI1000735A2 (es)
CA (1) CA2697562C (es)
CL (1) CL2010000254A1 (es)
CY (1) CY1112136T1 (es)
DK (1) DK2241554T3 (es)
EA (1) EA016335B1 (es)
ES (1) ES2373369T3 (es)
FR (1) FR2943667B1 (es)
GE (1) GEP20125460B (es)
HK (2) HK1148748A1 (es)
HR (1) HRP20110915T1 (es)
JO (1) JO2782B1 (es)
MA (1) MA31745B1 (es)
ME (1) ME00987B (es)
MX (1) MX2010003184A (es)
MY (1) MY145611A (es)
NZ (1) NZ584309A (es)
PE (1) PE20100714A1 (es)
PL (1) PL2241554T3 (es)
PT (1) PT2241554E (es)
RS (1) RS51962B (es)
SA (1) SA110310240B1 (es)
SG (1) SG165254A1 (es)
SI (1) SI2241554T1 (es)
TW (1) TWI419879B (es)
UA (1) UA102232C2 (es)
UY (1) UY32500A (es)
WO (1) WO2010112704A1 (es)
ZA (1) ZA201002121B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2162438A4 (en) * 2007-05-30 2011-07-06 Ind Swift Lab Ltd PROCESS FOR THE PREPARATION OF IVABRADINE HYDROCHLORIDE AND CORRESPONDING POLYMORPHIDE
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
CN103724266B (zh) * 2014-01-20 2018-12-04 山东诚创医药技术开发有限公司 去甲伊伐布雷定盐及其制备方法和应用
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN108530359A (zh) * 2017-03-01 2018-09-14 浙江京新药业股份有限公司 一种伊伐布雷定杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140049A (en) * 1965-04-02 1969-01-15 Alphachimie S A N-substituted tetrahydrobenzazepines
US3743731A (en) * 1971-03-16 1973-07-03 Schering Corp Substituted benzazepines for producing skeletal muscle relaxation
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2008065681A2 (en) * 2006-11-30 2008-06-05 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
CN101284813B (zh) * 2007-04-12 2012-08-15 上海优拓医药科技有限公司 伊伐布雷定的制备方法
EP2162438A4 (en) 2007-05-30 2011-07-06 Ind Swift Lab Ltd PROCESS FOR THE PREPARATION OF IVABRADINE HYDROCHLORIDE AND CORRESPONDING POLYMORPHIDE

Also Published As

Publication number Publication date
CA2697562A1 (fr) 2010-09-30
BRPI1000735A2 (pt) 2011-04-19
RS51962B (en) 2012-02-29
FR2943667A1 (fr) 2010-10-01
MX2010003184A (es) 2010-10-05
JP5107382B2 (ja) 2012-12-26
AU2010201058B2 (en) 2015-02-05
EP2241554A1 (fr) 2010-10-20
US20100249397A1 (en) 2010-09-30
ES2373369T3 (es) 2012-02-02
US8101747B2 (en) 2012-01-24
EA201000397A1 (ru) 2010-12-30
CN102603634A (zh) 2012-07-25
SA110310240B1 (ar) 2013-07-28
CN101851205B (zh) 2013-02-13
EA016335B1 (ru) 2012-04-30
GEP20125460B (en) 2012-03-26
UA102232C2 (uk) 2013-06-25
CY1112136T1 (el) 2015-11-04
KR101166630B1 (ko) 2012-07-19
HRP20110915T1 (hr) 2011-12-31
PE20100714A1 (es) 2010-10-30
NZ584309A (en) 2010-11-26
TW201040144A (en) 2010-11-16
ME00987B (me) 2012-06-20
EP2241554B1 (fr) 2011-09-07
CN102603634B (zh) 2014-04-16
ZA201002121B (en) 2010-11-24
JO2782B1 (en) 2014-03-15
PT2241554E (pt) 2011-10-17
WO2010112704A1 (fr) 2010-10-07
DK2241554T3 (da) 2011-12-12
HK1148748A1 (en) 2011-09-16
MA31745B1 (fr) 2010-10-01
TWI419879B (zh) 2013-12-21
AR075977A1 (es) 2011-05-11
MY145611A (en) 2012-03-05
HK1169827A1 (en) 2013-02-08
FR2943667B1 (fr) 2011-05-06
PL2241554T3 (pl) 2012-01-31
SG165254A1 (en) 2010-10-28
ATE523494T1 (de) 2011-09-15
CA2697562C (fr) 2012-05-15
AU2010201058A1 (en) 2010-10-14
CN101851205A (zh) 2010-10-06
JP2010241809A (ja) 2010-10-28
SI2241554T1 (sl) 2012-01-31
KR20100109526A (ko) 2010-10-08
CL2010000254A1 (es) 2011-04-25

Similar Documents

Publication Publication Date Title
PA8855501A1 (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
UY32499A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY31883A (es) Nuevo procedimiento de síntesis de 7,8-dimetoxi-1, 3-dihidro-2h-3-benzazepin-2-ona, y aplicación en la síntesis de ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EA201200498A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
UY32500A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY33893A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
EA201100230A1 (ru) Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
UY35108A (es) Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY34423A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY35149A (es) Nuevo procedimiento de síntesis del 3 -(2-bromo-4,5-dimetoxifenil) propanonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
UY35561A (es) Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
CL2012003579A1 (es) Procedimiento de sintesis de la ivabradina de formula (i) y de sus sales de adicion a un acido farmaceuticamente aceptable.
UY35068A (es) Nuevo procedimiento de síntesis del 3-(2-bromo-4,5-dimetoxifenil)propanonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY34685A (es) Nuevo procedimiento de síntesis de la ivabradinay de sus sales de adición a un ácido farmacéuticamente aceptable
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20201223